BiotechTube
Home/Iterum Therapeutics/Judith M. Matthews
JM

Judith M. Matthews

Chief Financial Officer

Iterum Therapeutics

Therapeutic Areas

Infectious DiseaseAntimicrobial Resistance

Iterum Therapeutics Pipeline

DrugIndicationPhase
ORLYNVAH™ (sulopenem)Uncomplicated Urinary Tract Infection (uUTI)Approved

Leadership Team at Iterum Therapeutics

CN
Corey N. Fishman
Chief Executive Officer
CR
Christine R. Coyne
Chief Commercial Officer
TL
Tom Loughman
Senior Vice President, Technical Operations
MD
Michael Dunne
Director
BP
Beth P. Hecht
Director
View full Iterum Therapeutics profile